(19)
(11) EP 3 496 844 A1

(12)

(43) Date of publication:
19.06.2019 Bulletin 2019/25

(21) Application number: 17841823.2

(22) Date of filing: 24.07.2017
(51) International Patent Classification (IPC): 
B01D 69/00(2006.01)
A61M 1/16(2006.01)
(86) International application number:
PCT/US2017/043432
(87) International publication number:
WO 2018/034797 (22.02.2018 Gazette 2018/08)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 15.08.2016 US 201662374983 P
13.07.2017 US 201715649084

(71) Applicant: Summit Innovation Labs, LLC
Norwood, OH 45212 (US)

(72) Inventors:
  • MAJETI, Satyanarayana
    Liberty Township, OH (US)
  • MEHANSHO, Haile
    Hamilton OH 45013 (US)
  • TZEGHAI, Ghebre Egziabher
    Wyoming OH 45215 (US)

(74) Representative: AWA Sweden AB 
P.O. Box 5117
200 71 Malmö
200 71 Malmö (SE)

   


(54) VASCULAR CALCIFICATION AND CARDIOVASCULAR/ASSOCIATED DISEASES PREVENTION AND TREATMENT